South Africa's Aspen says talks with GSK over thrombosis drugs continues
JOHANNESBURG (Reuters) - South Africa's biggest generic drug maker Aspen Pharmacare said on Thursday talks with Britain's GlaxoSmithKline about its $700 bid for drugs and a factory continues.
Aspen offered to buy GSK's thrombosis drug brands Arixtra and Fraxiparine, sales of which are in decline, along with a related French factory in June.
(Reporting by Tiisetso Motsoeneng; editing by David Dolan)
- Washington, DC city council raises minimum wage to $11.50/hr in 2016
- Winning ticket sold in California for Mega Millions lottery: official
- UPDATE 5-Mega Millions lottery winning tickets sold in California, Georgia -Officials
- India removes barriers to U.S. embassy as anger grows over diplomat's arrest
- U.N. told up to 500 killed in South Sudan clashes: diplomats